Search

Your search keyword '"Jandeleit-Dahm K"' showing total 213 results

Search Constraints

Start Over You searched for: Author "Jandeleit-Dahm K" Remove constraint Author: "Jandeleit-Dahm K"
213 results on '"Jandeleit-Dahm K"'

Search Results

1. Association of dietary patterns with diabetes-related comorbidities varies among diabetes endotypes

2. Association of dietary patterns with diabetes-related comorbidities varies among diabetes endotypes

3. Association of thyroid function with non‐alcoholic fatty liver disease in recent‐onset diabetes.

6. Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability

8. Comparison of diabetes distress and depression screening results of emerging adults with type 1 diabetes onset at different ages: findings from the German early-onset T1D study and the German Diabetes Study (GDS).

13. Oral Supplementation of an Alkylglycerol Mix Comprising Different Alkyl Chains Effectively Modulates Multiple Endogenous Plasmalogen Species in Mice

21. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus

22. Mitochondrial physiology: Gnaiger Erich et al ― MitoEAGLE Task Group

25. A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations.

26. Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

34. Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation.

38. The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes

39. Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice

40. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease.

41. Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

42. Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe −/− mice

46. Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

49. Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Catalog

Books, media, physical & digital resources